検索





検索





市場
/
株式
/
nasdaq-teva
/

Teva Pharmaceutical Industries Ltd

TEVA

ウォッチリストに追加

35.216USD

-1.034-2.85%

取引時間（ET）15分遅れの株価

40.99B時価総額

28.60直近12ヶ月PER



Teva Pharmaceutical Industries Ltd

35.216

-1.034-2.85%

概要金融ディスカッション分析企業名

概要

金融

ディスカッション

分析

企業名

詳細情報 Teva Pharmaceutical Industries Ltd 企業名

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

Teva Pharmaceutical Industries Ltdの企業情報



企業コードTEVA

会社名Teva Pharmaceutical Industries Ltd

上場日Feb 06, 2087

最高経営責任者「CEO」Francis (Richard D)

従業員数33892

証券種類Depository Receipt

決算期末Feb 06

本社所在地124 Dvora Hanevi'a St.

都市TEL AVIV-YAFO

証券取引所NASDAQ OMX NASDAQ Basic NYSE

国Israel

郵便番号6944020

電話番号97239148213

ウェブサイトhttps://www.tevapharm.com/

企業コードTEVA

上場日Feb 06, 2087

最高経営責任者「CEO」Francis (Richard D)

Teva Pharmaceutical Industries Ltdの経営陣



会社名

会社名/ポジション

ポジション

株式保有

変動額

Prof. Varda Shalev

Independent Director

22.50K

+42.80%

Ms. Christine (Chris) Fox

Executive Vice President - U.S. Commercial

14.28K

Mr. Amir Elstein

Independent Director

Mr. Mark Sabag

Executive Vice President - International Markets Commercial

Dr. Sol J. Barer, Ph.D.

Independent Chairman of the Board

Ms. Rosemary A. (Rose) Crane

Independent Director

Mr. Gerald M. (Jerry) Lieberman

Independent Director

Mr. Richard Daniell

Executive Vice President - European Commercial

Mr. Roberto A. Mignone

Independent Director

Dr. Perry D. Nisen, M.D., Ph.D.

Independent Director

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Prof. Varda Shalev

Independent Director

22.50K

+42.80%

Ms. Christine (Chris) Fox

Executive Vice President - U.S. Commercial

14.28K

Mr. Amir Elstein

Independent Director

Mr. Mark Sabag

Executive Vice President - International Markets Commercial

Dr. Sol J. Barer, Ph.D.

Independent Chairman of the Board

Ms. Rosemary A. (Rose) Crane

Independent Director

収益内訳

通貨: USD更新時刻: Mon, Apr 6

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

Generic products

9.42B

54.59%

AUSTEDO

2.26B

13.10%

Other

1.51B

8.73%

Anda

1.50B

8.67%

AJOVY

673.00M

3.90%

他の

1.90B

11.01%

地域別USD

会社名

収益

比率

United States

9.19B

53.23%

Europe

5.04B

29.21%

International Markets

2.16B

12.53%

Other

870.00M

5.04%

事業別

地域別

事業別USD

会社名

収益

比率

Generic products

9.42B

54.59%

AUSTEDO

2.26B

13.10%

Other

1.51B

8.73%

Anda

1.50B

8.67%

AJOVY

673.00M

3.90%

他の

1.90B

11.01%

株主

更新時刻: Thu, Feb 19

株主統計

種類

株主統計

比率

Harel Insurance Investments and Financial Services Ltd

3.95%

Phoenix Investment and Finances Ltd

3.67%

WCM Investment Management

3.51%

Menora Mivtachim Insurance Ltd.

3.38%

Clal Insurance Enterprises Holdings Ltd.

3.30%

他の

82.20%

株主統計

比率

Harel Insurance Investments and Financial Services Ltd

3.95%

Phoenix Investment and Finances Ltd

3.67%

WCM Investment Management

3.51%

Menora Mivtachim Insurance Ltd.

3.38%

Clal Insurance Enterprises Holdings Ltd.

3.30%

他の

82.20%

種類

株主統計

比率

Investment Advisor

27.93%

Investment Advisor/Hedge Fund

13.05%

Hedge Fund

6.67%

Insurance Company

6.60%

Sovereign Wealth Fund

3.06%

Research Firm

2.16%

Pension Fund

1.74%

Bank and Trust

0.99%

Family Office

0.92%

他の

36.88%

機関投資家保有株



更新時刻: Sun, Apr 5

報告期間

機関投資家数

保有株式数

比率

変動額

2026Q1

1226

725.07M

62.27%

+9.19M

2025Q4

1170

665.23M

57.84%

-137.26M

2025Q3

1124

742.23M

64.70%

-84.92M

2025Q2

1100

749.18M

65.31%

-13.97M

2025Q1

1130

727.69M

63.46%

-282.41K

2024Q4

1087

683.52M

59.66%

-22.86M

2024Q3

1029

663.95M

58.60%

-6.13M

2024Q2

1002

631.05M

55.72%

-26.20M

2024Q1

950

595.83M

53.15%

-34.73M

2023Q4

932

601.27M

53.63%

+7.51M

詳細を見る

株主動向



会社名

保有株式数

比率

変動額

変動率

日付

Harel Insurance Investments and Financial Services Ltd

44.95M

3.86%

+7.26M

+19.25%

Dec 31, 2025

Phoenix Investment and Finances Ltd

41.09M

3.53%

-208.11K

-0.50%

Dec 31, 2025

WCM Investment Management

14.01M

1.2%

+13.76M

+5492.83%

Dec 31, 2025

Menora Mivtachim Insurance Ltd.

39.32M

3.38%

+395.89K

+1.02%

Dec 31, 2025

Clal Insurance Enterprises Holdings Ltd.

37.40M

3.21%

+5.92M

+18.79%

Dec 31, 2025

Migdal Insurance and Financial Holdings Ltd

37.40M

3.21%

+4.82M

+14.79%

Dec 31, 2025

BlackRock Institutional Trust Company, N.A.

35.79M

3.07%

+870.38K

+2.49%

Dec 31, 2025

Norges Bank Investment Management (NBIM)

35.18M

3.02%

+33.32M

+1786.80%

Dec 31, 2025

Lingotto Investment Management LLP

28.42M

2.44%

-166.02K

-0.58%

Dec 31, 2025

Fidelity Management & Research Company LLC

23.59M

2.03%

+3.41M

+16.88%

Dec 31, 2025

詳細を見る

配当金



過去5年間の配当金総支払額は 0.00 米ドルである。

日付

配当金

権利確定日

支払日

配当落ち日

データなし

株式分割



日付

配当落ち日

種類

比率

データなし

日付

配当落ち日

種類

比率

データなし

KeyAI



Teva Pharmaceutical Industries Ltd

詳細情報 Teva Pharmaceutical Industries Ltd 企業名

Teva Pharmaceutical Industries Ltdの企業情報

Teva Pharmaceutical Industries Ltdの経営陣

収益内訳

株主

機関投資家保有株

株主動向

関連ETF

配当金

株式分割